T. Rowe Price Associates’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $104M | Sell |
1,584,321
-345,798
| -18% | -$22M | 0.01% | 602 |
|
|
2025
Q4 | $123M | Sell |
1,930,119
-436,729
| -18% | -$27.2M | 0.01% | 588 |
|
|
2025
Q3 | $130M | Buy |
2,366,848
+500,871
| +27% | +$20.6M | 0.01% | 561 |
|
|
2025
Q2 | $61.7M | Sell |
1,865,977
-127,919
| -6% | -$4.45M | 0.01% | 680 |
|
|
2025
Q1 | $80.1M | Sell |
1,993,896
-631,185
| -24% | -$29M | 0.01% | 594 |
|
|
2024
Q4 | $123M | Sell |
2,625,081
-539,864
| -17% | -$28M | 0.01% | 528 |
|
|
2024
Q3 | $167M | Buy |
3,164,945
+806,602
| +34% | +$45M | 0.02% | 469 |
|
|
2024
Q2 | $128M | Sell |
2,358,343
-572,605
| -20% | -$34.6M | 0.02% | 493 |
|
|
2024
Q1 | $205M | Sell |
2,930,948
-313,302
| -10% | -$24.2M | 0.03% | 416 |
|
|
2023
Q4 | $271M | Buy |
3,244,250
+2,232,623
| +221% | +$80.8M | 0.04% | 358 |
|
|
2023
Q3 | $29.8M | Sell |
1,011,627
-73,686
| -7% | -$2.45M | ﹤0.01% | 822 |
|
|
2023
Q2 | $35.4M | Sell |
1,085,313
-86,716
| -7% | -$3.21M | ﹤0.01% | 800 |
|
|
2023
Q1 | $41.2M | Buy |
1,172,029
+64,168
| +6% | +$2.62M | 0.01% | 733 |
|
|
2022
Q4 | $50.8M | Buy |
1,107,861
+14,414
| +1% | +$620K | 0.01% | 657 |
|
|
2022
Q3 | $53M | Buy |
1,093,447
+595,708
| +120% | +$28.7M | 0.01% | 631 |
|
|
2022
Q2 | $19.6M | Buy |
497,739
+35,256
| +8% | +$1.42M | ﹤0.01% | 1169 |
|
|
2022
Q1 | $17M | Buy |
462,483
+313,044
| +209% | +$11.1M | ﹤0.01% | 1269 |
|
|
2021
Q4 | $6.81M | Buy |
149,439
+119,982
| +407% | +$4.63M | ﹤0.01% | 1462 |
|
|
2021
Q3 | $1.05M | Buy |
29,457
+1,016
| +4% | +$29.9K | ﹤0.01% | 2040 |
|
|
2021
Q2 | $563K | Buy |
28,441
+1,261
| +5% | +$29.6K | ﹤0.01% | 2335 |
|
|
2021
Q1 | $632K | Buy |
27,180
+3,654
| +16% | +$78K | ﹤0.01% | 2252 |
|
|
2020
Q4 | $489K | Sell |
23,526
-636,628
| -96% | -$11.6M | ﹤0.01% | 2248 |
|
|
2020
Q3 | $14.3M | Buy |
+660,154
| New | +$15.4M | ﹤0.01% | 1219 |
|
|
2018
Q1 | – | Sell |
-427,148
| Closed | -$3.48M | – | 2559 |
|
|
2017
Q4 | $3.48M | Buy |
427,148
+1,890
| +0.4% | +$21.5K | ﹤0.01% | 1473 |
|
|
2017
Q3 | $6.17M | Buy |
+425,258
| New | +$5.81M | ﹤0.01% | 1410 |
|
|
2013
Q4 | – | Sell |
-1,431,573
| Closed | -$10.9M | – | 2491 |
|
|
2013
Q3 | $10.9M | Sell |
1,431,573
-42,285
| -3% | -$454K | ﹤0.01% | 1250 |
|
|
2013
Q2 | $17.1M | Buy |
+1,473,858
| New | +$11.6M | ﹤0.01% | 1111 |
|
Other funds holding CYTK
VPM
VCM
ACA
